1. Panigrahi A and Shaw JR. Perioperative Use of Activated Prothrombin Complex Concentrates. Anesthesiology 2025 [IN PRESS]

2. Douketis J, Li N, St John M, Nixon J, Moffat K, Shaw JR, Syed S, Schulman S, Gross PL, Spyropoulos AC. Perioperative Management of Direct Oral Anticoagulants in Patients Having a High-Bleed-Risk Surgery or Procedure: the PAUSE-2 Pilot Study. J Thromb Haemost 2025 [IN PRESS]

3. Shaw JR and Levy JH. Emergent Cardiac Surgery, Andexanet Alfa-Induced Heparin Resistance, and Prothrombotic Effects: Coagulation Chaos? J Thromb Haemost 2025; 23(5): 1469-1472

4. Shaw JR, Li N, Grussé M, Van Dreden P, St John M, Nixon J, Spyropoulos AC, Schulman S, Levy JH, Carrier M, Douketis JD. Influence of DOAC Levels and Thrombin Generation on Postoperative Bleeding [SONAR]: A Nested Case-Control Study. Thromb Haemost 2025. doi: 10.1055/a-2521-0923. Online ahead of print. 

5. Shaw JR, Nopp S, Stavik B, Youkhana K, Michels AL, Kennes S, Rak J, ten Cate H. Thrombosis, Translational Medicine, and Biomarker Research: Moving the Needle. J Am Heart Assoc 2024; 24:e038782. doi:10.1161/JAHA.124.038782.

6. Shaw JR, Almujalli A, Xu Y, Levy JH, Schulman S, Siegal D, Dowlatshahi D, Tokessy M, Buyukdere H, Carrier M, Castellucci LA. Prothrombin complex concentrate for direct factor Xa inhibitor-associated bleeding or before urgent surgery. Thromb Res 2024; 243: 109172. doi: 10.1016/j.thrombres.2024.109172. Epub 2024 Sep 24.

7. Levy JH, Shaw JR, Castellucci LA, Connors JM, Douketis J, Lindhoff-Last E, Rocca B, Samama CM, Siegal D, Weitz JI. Reversal of direct oral anticoagulants: Guidance from the SSC of the ISTH. J Thromb Haemost. 2024; Jul 17:S1538-7836(2)00426-4 Online ahead of print. 

8. Hrubesz G, Dwyer K, McIsaac D, Sood M, Clark E, Douketis J, Carrier M, Shaw JR. Perioperative Management of Apixaban in Patients with Advanced CKD Undergoing a Planned Invasive Procedure. Blood Adv. 2024 Feb 13;8(3):732-735.

9. Shaw JR, Li N, Abdulrehman J, Stella SF, St John M, Nixon J, Spyropoulos AC, Schulman S, Wang TF, Carrier M, Douketis JD. (2023) Periprocedural Management of Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Active Cancer. J Thromb Haemost. 2024;22(3): 727-737. doi:10.1016/j.jtha.2023.10.082. PMID: 37949316

10. Shaw JR, James T, Douxfils J, Dargaud Y, Levy JH, Brinkman HJM, Shorr R, Siegal D, Castellucci LA, Gross P, Khalife R, Sperling C, Page D, Fergusson D, Carrier M. (2023) Thrombin generation, bleeding and hemostasis in humans: Protocol for a scoping review of the literature. PLoS One. 2023 Nov 1;18(11)

11. Shaw JR, Castellucci LA., Siegal D., Carrier M. DOAC-associated bleeding, hemostatic strategies and thrombin generation assays - a review of the literature. J Thromb Haemost. 2023 Mar;21(3):433-452

12. Aziz J., Wang TF., Siegal D., Douketis J., Le Gal G., Carrier M., Shaw JR. Thrombotic and bleeding outcomes following the perioperative interruption of anticoagulation among patients with nonvalvular atrial fibrillation and active cancer. J Thromb Haemost. 2023 Apr;21(4):933-943.

13. Shaw JR, Li N., Nixon J., Moffat KA., Spyropoulos AC., Schulman S., Douketis JD. Coagulation assays and direct oral anticoagulant levels among patients having an elective surgery or procedure. J Thromb Haemost. 2022 Dec;20(12):2953-2963

14.Shaw JR, Kumar V., Mallick R., Carrier M., Ilich A., Key N., Wells P. (2020) Biomarker-enhanced VTE risk stratification in ambulatory patients with cancer. Thromb Res; 196: 437-443

15. Shaw JR, Li N., Vanassche T., Coppens M., Spyropoulos A.C., Syed S., Radwi M., Duncan J., Schulman S., Douketis J. (2020) Predictors of preprocedural direct oral anticoagulant levels in patients having an elective surgery or procedure. Blood Advances; 4(15): 3520-3527

16. Shaw JR, Kaplovitch E., Douketis J. (2020) Periprocedural management of oral anticoagulation. Med Clin North Am; 104(4): 709-726

17. Shaw JR., Siegal D.M. (2020). Prothrombin complex concentrates for DOAC-associated bleeding, global coagulation assays, and assessments of clinical hemostasis: How to gauge the impact? Res Pract Thromb Haemost; 4(5): 677-679

18. Shaw JR, Douketis J., Le Gal G., Carrier M (2019). Periprocedural interruption of anticoagulation in patients with cancer-associated venous thromboembolism: An analysis of thrombotic and bleeding outcomes. J Thromb Haemost; 17(7): 1171-1178

19. Shaw JR, Siegal D.M. (2018). Pharmacological reversal of the direct oral anticoagulants – A comprehensive review of the literature. Res Pract Thromb Haemost; 2:251-265